Literature DB >> 8832081

Potentiation of purinergic transmission by angiotensin in prostatic rat vas deferens.

C S Sum1, D C Wan, W T Cheung.   

Abstract

1. Angiotensin II (AII) elicited only a minute, if any, direct contractile response in smooth muscle cells of prostatic rat vas deferens, but it potentiated contractile responses to field stimulation. 2. Angiotensin-potentiated contractile response to field stimulation was concentration-dependent, and the order of potency was AII > AIII approximately AI. The EC50 of AII was 8.11 +/- 2.79 nM. 3. AII did not modify the contractile response of exogenous noradrenaline (NA) on non-stimulated prostatic vas deferens. Furthermore, the concentration-response curve for AII-potentiated contractile responses to field stimulation in reserpine-treated rats did not significantly differ from the control group. 4. Desensitization of purinoceptors with 30 microM alpha, beta-methylene-ATP almost completely abolished the potentiation of the contractile response to field stimulation by AII. 5. The response to AII in the prostatic rat vas deferens was blocked by the AT1 selective antagonist losartan, but not by the AT2 selective antagonist CGP 42112. Losartan acted as a competitive antagonist with a pA2 value of 8.75. 6. In conclusion, AII potentiated purinergic transmission in the prostatic rat vas deferens via the AT1 receptor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8832081      PMCID: PMC1909690          DOI: 10.1111/j.1476-5381.1996.tb15569.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Drug antagonism and pAx.

Authors:  H O SCHILD
Journal:  Pharmacol Rev       Date:  1957-06       Impact factor: 25.468

Review 2.  Renin-angiotensin system: biochemistry and mechanisms of action.

Authors:  M J Peach
Journal:  Physiol Rev       Date:  1977-04       Impact factor: 37.312

Review 3.  Pharmacology of angiotensin.

Authors:  D Regoli; W K Park; F Rioux
Journal:  Pharmacol Rev       Date:  1974-06       Impact factor: 25.468

4.  Modulation of tachyphylaxis to angiotensin II in rabbit isolated aorta by the angiotensin AT1 receptor antagonist, losartan.

Authors:  M J Robertson; A Wragg; K L Clark
Journal:  Regul Pept       Date:  1994-02-24

Review 5.  Adrenergic facilitation by angiotensin: does it serve a physiological function?

Authors:  B G Zimmerman
Journal:  Clin Sci (Lond)       Date:  1981-04       Impact factor: 6.124

6.  Adrenergic and 'non-adrenergic' components in the contractile response of the vas deferens to a single indirect stimulus.

Authors:  J C McGrath
Journal:  J Physiol       Date:  1978-10       Impact factor: 5.182

7.  The effect of pithing and of nerve stimulation on the depletion of noradrenaline by reserpine in the rat anococcygeus muscle and vas deferens.

Authors:  J S Gillespie; J C McGrath
Journal:  Br J Pharmacol       Date:  1974-12       Impact factor: 8.739

8.  Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.

Authors:  M A Ondetti; B Rubin; D W Cushman
Journal:  Science       Date:  1977-04-22       Impact factor: 47.728

9.  Characterization of contractile response to angiotensin in epididymal rat vas deferens.

Authors:  C S Sum; W T Cheung
Journal:  Pharmacology       Date:  1995-08       Impact factor: 2.547

10.  Synergistic effects of angiotensin and adenosine in the renal microvasculature.

Authors:  H Weihprecht; J N Lorenz; J P Briggs; J Schnermann
Journal:  Am J Physiol       Date:  1994-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.